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The nucleus accumbens (NAcc) has been suggested as a possible target for deep brain
stimulation (DBS) in the treatment of obesity. Our hypothesis was that NAcc-DBS would
modulate brain regions related to reward and food intake regulation, consequently reducing
the food intake and, finally, the weight gain. Therefore, we examined changes in brain glu-
cose metabolism, weight gain and food intake after NAcc-DBS in a rat model of obesity.
Procedures
Electrodes were bilaterally implanted in 2 groups of obese Zucker rats targeting the NAcc.
One group received stimulation one hour daily during 15 days, while the other remained as
control. Weight and daily consumption of food and water were everyday registered the days
of stimulation, and twice per week during the following month. Positron emission tomogra-
phy (PET) studies with 2-deoxy-2-[18F]fluoro-D-glucose (FDG) were performed 1 day after
the end of DBS. PET data was assessed by statistical parametric mapping (SPM12) soft-
ware and region of interest (ROI) analyses.
Results
NAcc-DBS lead to increased metabolism in the cingulate-retrosplenial-parietal association
cortices, and decreased metabolism in the NAcc, thalamic and pretectal nuclei. Further-
more, ROIs analyses confirmed these results by showing a significant striatal and thalamic
hypometabolism, and a cortical hypermetabolic region. However, NAcc-DBS did not induce
a decrease in either weight gain or food intake.
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Conclusions
NAcc-DBS led to changes in the metabolism of regions associated with cognitive and
reward systems, whose impairment has been described in obesity.
Introduction
Obesity is defined as abnormal or excessive fat accumulation which may impair health [1].
The prevalence of obesity has reached epidemic levels, and its comorbid conditions cause at
least 2.8 million deaths per year worldwide [2]. In addition, obesity is a risk factor for many
other highly prevalent diseases [3].
Initial anti-obesity treatments focus on diet and exercise routines [4]. However, in refrac-
tory patients, specialists turn to pharmacological and surgical procedures, which can cause
serious adverse effects and fail to control the disease in the long term [5,6]. Therefore, new
therapeutic approaches must be found to reduce the prevalence of obesity. Among them, deep
brain stimulation (DBS) seems promising for treatment-resistant obesity. This therapy
involves sending electric stimuli from a pulse generator to brain nuclei via electrodes in order
to modify impaired function. However, the mechanism of action of this approach remains
unknown. In this sense, the traditional concept of an ablative effect of high-frequency (HF)
DBS (100–160 Hz) [7,8] is now being replaced. In fact, there is growing interest in alternative
proposals, such as the idea that HF-DBS could cause an ‘informational lesion’ [9] or disruption
of the neural informational flow [10] in the target structure, which would produce therapeutic
benefits. Therefore, inadequate signals from a specific nucleus could be isolated by stimulating
a downstream target and hence correcting the malfunction of the neural circuit. In any case,
DBS offers important benefits over ablative neurosurgery, such as reduced invasiveness, possi-
ble reversibility, and the possibility of in vivo adjustment of the stimulus applied [11]. Further-
more, several authors have shown stereotaxic surgery to be safe in clinical procedures [12–15],
thus reinforcing its potential application to a broader range of diseases. In this sense, DBS has
been validated as a palliative treatment in motor diseases [16] and obsessive-compulsive disor-
der [17], and its potential role has been investigated in other neuropsychiatric disorders [18].
The nucleus accumbens (NAcc) has received much attention as a key target structure of the
reward system in the treatment of obesity [19–21]. Therefore, NAcc-DBS could modulate the
reward processes related to food intake and lead to weight reduction [7,20,22]. Two case
reports assessing bilateral NAcc-DBS in obese patients show significant weight loss [23,24].
Interestingly, the second report described a patient with pathological obesity due to cranio-
pharyngioma surgery [24], thus highlighting the interaction between the homeostatic and
reward mechanisms involved in feeding. The communication between these neural systems
would be mediated by an interplay between the lateral hypothalamus (LH), ventral tegmental
area (VTA), and NAcc, in which leptin would play a central role [20].
Neuroimaging offers a variety of powerful tools to study the regions involved in the patho-
physiology of obesity, as well as those modulated by DBS. In particular, positron emission
tomography (PET) with 2-deoxy-2-[18F]fluoro-D-glucose (FDG) is a suitable technique for
characterizing functional neuronal networks in small animals, and has proven useful for eluci-
dating the mechanism of action of DBS [25,26]. In fact, we previously showed that LH-DBS
induced metabolic changes in brain regions related to the control of food intake and reduced
weight gain in a leptin signal–deficient model of obesity (obese Zucker rat) [27].
Given this background, and considering the hypothesis that DBS can block the impaired
signaling sent by VTA and LH in the absence of the influence of leptin, we assessed the
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el Bueno. The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
metabolic changes induced by NAcc-DBS in our previous animal model by applying an identi-




The obese Zucker rat was selected as an animal model of treatment resistant obesity, which is
representative of the potential beneficiaries of this therapy. It is homozygous for a truncated
form of the leptin receptor and hence has genetic resistance to this hormone. Leptin is released
by adipose tissue in proportion to its extension and the amount of lipids ingested during
meals. It targets the lateral LH, ventromedial hypothalamus and VTA [20,29], and acts as a sig-
nal to stop eating. Consequently, Zucker rats experience hyperphagia, hyperinsulinemia, and
hyperlipidemia; which lead to spontaneous obesity [30].
In this work, fifteen adult male obese Zucker rats (fa/fa-, Charles Rivers Laboratories,
Spain) (10-week old) were housed individually in a temperature- and humidity-controlled
room on a 12 h dark/light cycle with food (standard laboratory chow) and water available ad
libitum. Weight, food and water consumption were monitored daily during the 15 days of
stimulation, and twice per week during the following month. Measurements were always col-
lected at the same time of the day. Prior to the PET study, animals were deprived of food but
allowed free access to water for 6–8 hours. The study design is shown in Fig 2.
All experimental animal procedures were conducted according to European Communities
Council Directive 2010/63/EU and approved by the Ethics Committee for Animal Experimen-
tation of Hospital Gregorio Marañón.
Surgery
Stereotaxic procedures were performed at 10 weeks-age under a mixture of ketamine/xylazine
(100/10 mg/kg). Concentric bipolar platinum-iridium electrodes (MS303/8-AIU/Spc, Bilaney
Consultants GmbH, Germany) were bilaterally implanted to target the NAcc core (+1.2 mm
posterior and +1.5 mm lateral from bregma, -8.2 mm ventral from the dura) [31]. Electrodes
were fixed to the skull bone with acrylic dental cement (Technovit, Heraeus-Kulzer, Germany)
reinforced with four small stainless steel screws attached to the skull. Ceftriaxone (100 mg/kg
IM) and buprenorphine (0.1 mg/kg IP) were administered during 5 days as postoperative care.
The correct electrode location verification is shown in Fig 3.
Remarkably, although the electrodes were implanted in the NAcc core, the selected stimula-
tion protocol is expected to directly affect a wider area, including also the NAcc shell [32].
Therefore, we will refer to the NAcc as the target of stimulation, without distinguishing
between subregions.
DBS protocol
DBS started 7 days after surgery to allow the animals sufficient recovery time. Animals were
divided into 2 groups: NAcc-sham (N = 9) (surgery with electrodes implantation but no stimu-
lation) and NAcc-DBS (N = 6) (surgery plus stimulation). As animals could freely move when
receiving the stimulation into their cages, the stimulator wire was susceptible of snagging due
to animals movements. Therefore, NAcc-sham animals were not plugged to the stimulator in
“off position” in order to avoid losing any surgical implant.
DBS was performed with an isolated stimulator device (CS 120 8i, CIBERTEC S.A., Spain)
set at a constant current of 150 μA (130 Hz) and a pulse width of 100 μs (biphasic stimulation
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mode). Stimulation was applied for 1 hour/day over 15 days. These settings were chosen based
on previous preclinical and clinical studies [25,33,34].
Imaging studies
PET studies were acquired one day after the DBS protocol finished with a small-animal PET/
CT scanner (ARGUS PET/CT, SEDECAL, Spain), under anesthesia with isoflurane (3% induc-
tion, 1.5% maintenance in 100% O2). 2-deoxy-2-[
18F]fluoro-D-glucose (FDG) (~37 MBq) was
injected through the tail vein, and animals were scanned for 45 min. Images were recon-
structed using a 2D-OSEM algorithm, Full Width at Half Maximum (FWHM) of 1.45 mm,
with a voxel size of 0.3875 x 0.3875 x 0.775 mm3 and an energy window of 400–700 keV.
Decay and dead-time corrections were applied.
We obtained two CT scans for each animal: at the end of the surgery to check the correct
placement of the electrodes, and simultaneously with the PET studies. CT studies were
acquired with the same scanner (340 mA, 40 kV, 360 projections, 8 shots, and 200 μm of
Fig 1. Study hypothesis. Schematic explanation of the hypothalamic-mesolimbic brain circuit state in the following:
A) healthy brain; B) obese Zucker brain; and C) obese Zucker brain with NAcc-DBS, showing the disruptive
mechanism of action theory [9,10]. Partially adapted from [20,28] [Arc: arcuate, LH: lateral hypothalamus, VTA:
ventral tegmental area, NAcc: nucleus accumbens].
https://doi.org/10.1371/journal.pone.0204740.g001
Fig 2. Study design. Design of the experimental procedures performed during the study in relation to the age of the
animals.
https://doi.org/10.1371/journal.pone.0204740.g002
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resolution) and reconstructed using an FDK algorithm (isotropic voxel size of 0.121 mm) [35].
Only animals with a correct placement of the electrodes were included in the study.
An MRI scan of a single non-operated animal was acquired with a 7-Tesla Biospec 70/20
scanner (Bruker, Germany) for use as anatomical template in the statistical analyses. A T2
spin-echo sequence was acquired, with TE = 33 ms and TR = 3732 ms. The scan parameters
were as follows: 34 slices measuring 0.8 mm in thickness; matrix size 256x256 pixels; and FOV
of 3.5x3.5 cm2. The artifact caused by the surface coil was corrected.
Data processing and statistical analysis
Intake and body weight. Daily food and water intake during the DBS period, as well as
average food ingested every 5 days, were used to evaluate the real consumption, as daily con-
sumption is a very noisy variable. Body weight results are expressed as the difference in weight
(%) with respect to baseline. Changes in weight and intakes were evaluated with GraphPad
Prism version 5.00 (GraphPad Software, USA), using a 2-way ANOVA to compare both
groups. Moreover, we used linear regression to evaluate the progression of weight changes
from baseline, comparing the obtained slope for each group by an ANCOVA analysis.
PET data. PET data followed a preprocessing registration protocol previously described
[27]. Briefly, PET scans were co-registered to a random reference CT scan by an automatic
method based on mutual information [36]. The MRI scan was also registered to the same spa-
tial frame with the same method. Images were studied by voxel-by-voxel and region of interest
(ROI) analyses. For the former methodology, PET registered images were normalized to global
mean brain intensity in accordance to Shinohara et al. criteria [37], and smoothed using a
Gaussian kernel of 0.96875 x 0.96875 x 1.9375 mm3 of FWHM. A whole brain (WB) mask was
segmented from the registered MRI study and applied to all PET images in order to eliminate
voxels outside the brain. Then, we performed a voxel-by-voxel analysis of data using SPM12
(http://www.fil.ion.ucl.ac.uk/spm/software/spm12/). Groups were compared using a two sam-
ple T-test, setting a significance threshold of p<0.005 uncorrected (voxel-level significance),
but cluster-based corrected in order to avoid type II errors [38]. Moreover, only significant
regions larger than 50 activated connected voxels were accepted aiming at reducing type I
error.
ROI analysis was performed to discard global differences in brain metabolism in order to
confirm the validity of WB as normalization region. Moreover, we studied other brain areas
with the aim of ratifying the previously observed group differences in the voxel-by-voxel
Fig 3. Electrodes placement verification. Representative sagittal (left) and axial (right) views of a CT scan registered
to the MR template of an animal next to the correspondent slice from [31] to verify the correct electrode location in the
NAcc.
https://doi.org/10.1371/journal.pone.0204740.g003
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procedure. Thus, masks from WB, NAcc, caudate-putamen (CPu), thalamus (Th) and cortex
(Cx) were segmented from the registered MRI. WB data was evaluated by means of standard-
ized uptake values (SUV); while the remaining ROIs data were normalized to the mean inten-
sity of the WB mask. Analyses were performed by a two sample T-test (p<0.05) in GraphPad
Prism version 5.00.
Results
In vivo study of the DBS effect
DBS in the NAcc produced significant metabolic differences in several brain regions. In fact,
voxel-by-voxel analysis revealed a decreased FDG uptake in NAcc, pretectal nucleus and thala-
mus (T = 5.66, pFDR<0.001). Moreover, an increased uptake of the radiotracer is located in a
cortical cluster that comprises different portions of the cingulate, retrosplenial and parietal
association cortices (T = 5.05, pFDR<0.001) (Fig 4, Table 1). Finally, there is also a slight hyper-
metabolic region in the ectorhinal–lateral entorhinal cortex (T = 4.73, punc<0.001, pFDR =
0.150), although it does not overcome the cluster-based correction thresholds.
ROI analysis did not reveal statistically significant global differences in brain metabolism
between sham and stimulated animals (pSUV>0.05), which supports the validity of WB mean
intensity as a normalization method in this study. Furthermore, we found significant changes
in NAcc (p<0.01), CPu (p<0.05), Th (p<0.01) and Cx (p<0.01) (Table 2).
Fig 4. NAcc-DBS effects on brain metabolism. Axial (left), coronal (upper right) and sagittal (lower right) views of the brain.
Colored PET overlays on the MR reference indicate increased FDG uptake (hot colors) or decreased FDG uptake (cold colors) 1 day
after the end of the stimulation in NAcc. Left (L), right (R), dorsal (D), ventral (V).
https://doi.org/10.1371/journal.pone.0204740.g004
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Weight
Neither significant differences in initial body weight were observed for the sham (382.20
±19.78 g) or DBS (358.99±36.00 g) groups, nor in the weight gain between groups (Fig 5).
Moreover, no statistically significant difference between slopes was found neither during the
DBS treatment nor during the posterior month.
Food and water intake
No significant differences were found in food and water intake (daily or accumulated) between
groups. (Fig 6). However, both food and water intake revealed a significant effect of the time
(food: F = 57.76, p<0.001; water: F = 44.02, p<0.001) and the interaction between factors
(food: F = 14.54, p<0.001; water: F = 7.748, p<0.001). Moreover, post-hoc test revealed differ-
ences between groups in food intake at the beginning of the DBS treatment (daily, day 3:
T = 3.01, p<0.05; accumulated, days 0 to 5: T = 3.02, p<0.05), showing reduced accumulated
food intake in the sham group compared to DBS animals.
Discussion
DBS has recently emerged as a potential therapy for treatment-resistant obesity. Thus, electri-
cally modulating the impaired activity of brain nuclei involved in the pathophysiology of obe-
sity, such as the NAcc, has proven to be effective in clinical studies. However, controversy
regarding effectiveness can be found in the literature, and even the modulatory results for
NAcc-DBS in the obese brain remain unclear. Therefore, identifying the functional conse-
quences of NAcc-DBS could help to better understand the physiological effects of this
approach and to decipher its mechanism of action.
Ours is the first study to apply small-animal FDG-PET to study brain networks undergoing
15 consecutive days of intermittent NAcc-DBS in an animal model of obesity. Thus, we
showed that NAcc-DBS modulated glucose metabolism in neuronal networks related to
Table 1. Changes in brain metabolic activity following 15 days of NAcc-DBS.
ROI Hemisphere k T "/# punc. pFWE pFDR
NAcc—PT—Th L & R 654 5.66 # < 0.001 < 0.001 < 0.001
Cg—RS—Pta L & R 923 5.05 " < 0.001 < 0.001 < 0.001
Ect—LEnt L 101 4.73 " < 0.001 0.253 0.150
ROI: Region of interest (Cg: cingulate cortex, Ect: ectorhinal cortex, LEnt: lateral entorhinal cortex, NAcc: nucleus accumbens, PT: pretectal nucleus, PTa: parietal
association cortex, RS: retrosplenial cortex, Th: thalamus). Hemisphere: left (L) and right (R). k: cluster size, T: T Student. Glucose metabolism: increase (") and decrease
(#). p: p value (unc: uncorrected, FWE: family wise error, FDR: false discovery rate).
https://doi.org/10.1371/journal.pone.0204740.t001
Table 2. ROIs analysis results.
ROI WBSUV NAcc CPu Th Cx
Sham 58.15 ± 8.28 1.30 ± 0.06 1.32 ± 0.05 1.20 ± 0.04 0.90 ± 0.11
DBS 51.38 ± 8.97 1.20 ± 0.02 1.24 ± 0.05 1.12 ± 0.01 1.08 ± 0.07
T 1.50 3.57 2.91 3.96 3.78
p<0.01
p<0.05
Data: mean ± SD, ROI: region of interest (WB: whole brain, NAcc: nucleus accumbens, CPu: caudate putamen, Th: thalamus, Cx: cortex), SUV: standardized uptake
value, T: T Student
https://doi.org/10.1371/journal.pone.0204740.t002
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reward and memory systems. However, we did not observe a significantly lower weight gain in
animals that underwent NAcc-DBS.
Brain metabolism
Our PET data reveal a reduction in NAcc metabolism after 15 days of intermittent stimulation
(1 hour per day). This finding could be consistent with reported neural informative disruption
theories [9,10]. In this sense, the action potentials produced by NAcc would be governed by
the stimulation pulses, with the result that DBS would ‘capture’ NAcc activity [9].
Moreover, one day after the DBS protocol had finished, NAcc-DBS produced a modulation
pattern in brain metabolism that is similar to that observed with LH-DBS [27]. In fact, NAcc-
DBS decreased glucose metabolism in the caudate-putamen, an effect which has also been
Fig 5. NAcc-DBS does not reduced weight gain. Weight difference (in percentage) with respect to weight recorded
before DBS (baseline) in sham and DBS groups. Values are expressed as mean ± SEM. The gray-striped area indicates
the DBS application period.
https://doi.org/10.1371/journal.pone.0204740.g005
Fig 6. Neither food nor water intake are reduced by NAcc-DBS. Food (A) and water (B) consumption during DBS treatment in sham and DBS groups. Lines
represent the mean daily intake of each group, while bars are referred to average consumption over 5 consecutive days. 5 days after stimulation are also shown for
the accumulated intake (#p<0.05; ##p<0.01).
https://doi.org/10.1371/journal.pone.0204740.g006
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shown in previous reports on major depression [39,40]. These nuclei are in close communica-
tion with the cortex and mediate motor and cognitive functions [41,42]. Indeed, patients with
a tendency towards obesity exhibited hyperactivation of the cortico-striato-thalamic pathway
in response to a food-dependent reward feeling [43]. Similarly, food images increased glucose
metabolism in the striatum of obese patients, while lowering baseline D2 receptor density [44].
This finding may reflect compensatory downregulation owing to the frequent transient
increases in dopamine levels associated with recurrent overstimulation of the reward circuit by
eating [45]. Consequently, this overstimulation might be counteracted by NAcc-DBS, as it
reduced glucose metabolism in the striatum and thalamus.
NAcc-DBS also increased metabolism in the retrosplenial cortex, which plays a direct role
in the consolidation of long-term memory owing to its association with the hippocampus, the
parahippocampal region, and the thalamic nuclei [46–48]. Therefore, retrosplenial dysfunction
could be caused by hippocampal damage and consequently contribute to the impact of hippo-
campal damage [49], thus supporting the idea that the thalamic nuclei depend on each other
in memory and learning tasks [47,49]. Obesity has been related to defective hippocampal activ-
ity [48], which leads to cognitive deficiency in obese patients [50] and obese Zucker rats [51].
Given the strong connectivity between both structures [46], it seems reasonable that the
increased metabolism observed in the cortical region might have an effect on defective hippo-
campal processes, thus improving the damaged memory function described in this animal
model. However, behavioral experiments must be performed to corroborate these findings.
Of note, previous studies of the consequences of bilateral NAcc-DBS assessed by in vivo
functional imaging were mainly focused on the acute effect of the NAcc-DBS (e.g. [52–55]) or
applied a continuous stimulation protocol during prolonged periods [56,57], thus preventing
them from being compared with the results we report here. To this end, further research
should be carried out to uncover the benefits and modulatory consequences resulting from dif-
ferent stimulation protocols.
Body weight and food and water intake
Given the essential role of leptin in the mesolimbic circuit, the NAcc was selected as the DBS
target for the obese Zucker rat [58,59]. Consequently, leptin regulates the mesolimbic reward
centers, which include the NAcc, thus promoting dopamine (DA) synthesis [59] or release
[60] and inducing a food-associated reward. However, the NAcc lacks leptin receptors, and its
influence is mediated by VTA and LH [20]. Therefore, obese leptin-resistant animals present
impaired feelings of satiety and reward, which lead them to increase their caloric intake
[61,62].
Importantly, leptin receptor is present in dopaminergic neurons of the VTA, which directly
project to the NAcc and receive afferent inputs from LH neurons expressing leptin receptor
[58]. In fact, the increase in DA produced by food intake in the NAcc is inhibited by leptin sig-
nals in the VTA, which also induce cessation of food intake [59]. Neto et al. reported lower
baseline DA and serotonin levels in Zucker rats than in Wistar rats and unchanged NAcc-DA
flow when leptin is intranasally administered to Zucker rats, as opposed to a clear increase in
Wistar rats [63]. Furthermore, these alterations seem to be exclusive to the obese Zucker rat
strain, which exhibited lower striatal DA transporter levels than their lean littermates (+/fa)
[64]. These findings reinforced the idea of DAergic modulation induced by leptin in the
reward system, which is directly hampered in the Zucker rat.
Given the neural disruption theories applying to the mechanism of action of DBS [9,10],
stimulating the NAcc would do the following: 1) isolate this structure from the VTA and LH
signals, since they promote food intake owing to the absence of leptin influence; and 2) recover
Deep brain stimulation in obesity: A preclinical PET study
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normal functioning of the NAcc by directly taking charge of its activity. However, in contrast
with our previous results with LH-DBS [27], NAcc-DBS did not reduce weight gain, possibly
owing to the firm anorexigenic modulation of the LH and ventromedial hypothalamus by lep-
tin [7]. In this sense, although NAcc-DBS was expected to modulate the impaired function of
the reward system [65,66], it would not be able to resolve the imbalance caused by the lack of
leptin signal in the hypothalamus.
In addition, van der Plasse et al. also reported absence of variation in average food intake
when DBS was applied to the NAcc core of Wistar rats, whereas stimulation of the NAcc
medial shell increased food intake [67]. Then, the fact that the stimulation could have affected
both the core and the shell could explain the lack of anti-obesity effect in NAcc-DBS animals.
Importantly, the present study was based on a genetic model of obesity; in other words, a
diet-induced model of obesity could show different effects. Zhang et al. reported that long-
term DBS applied to the NAcc shell attenuated weight gain in rats with diet-induced obesity
[68]. Similar results were also obtained in a mouse model of binge eating after NAcc shell DBS,
although no related differences were observed after stimulating the NAcc core [22]. These
results highlight the need to clarify the role of NAcc substructures before this nucleus can be
considered a clinical target for DBS in obesity.
Limitations of the study
Our study is subject to limitations. On the one hand, we cannot extrapolate the effects
observed in obese Zucker rats to lean Zucker rats or other animal models of obesity. Neverthe-
less, our animal model is representative of a particularly resistant kind of obesity, which could
potentially benefit from NAcc-DBS depending on the genetic background. We selected the
DBS parameters for three main reasons: the success obtained in previous approaches using
bilateral DBS [23,24] and similar stimulation protocols [22,27,34,69]; the tolerance associated
with continuous DBS treatments [70,71]; and the technical difficulties in obtaining portable
rat stimulators in our facilities. Nevertheless, DBS protocols which were closer to the current
clinical scenario may reveal larger differences in weight gain [22,68].
Conclusion
In conclusion, we describe an experimental approach to evaluate the neuromodulatory conse-
quences of NAcc as a target of DBS in the treatment of obesity. Although no substantial effects
in weight or intake parameters were observed, we proved that brain regions that were func-
tionally impaired in obesity were modulated by an intermittent NAcc-DBS protocol.
Acknowledgments
We thank Alexandra de Francisco, Yolanda Sierra, Iván Balsa and Diego Romero for their sup-
port in stereotaxic surgery, animal handling, and acquisition of imaging studies.
Author Contributions
Conceptualization: Marı́a Luisa Soto-Montenegro.
Data curation: Manuel Desco, Marı́a Luisa Soto-Montenegro.
Formal analysis: Marta Casquero-Veiga.
Funding acquisition: Manuel Desco, Marı́a Luisa Soto-Montenegro.
Investigation: Marta Casquero-Veiga, Marı́a Luisa Soto-Montenegro.
Deep brain stimulation in obesity: A preclinical PET study
PLOS ONE | https://doi.org/10.1371/journal.pone.0204740 September 27, 2018 10 / 14
Methodology: Marta Casquero-Veiga, David Garcı́a-Garcı́a, Marı́a Luisa Soto-Montenegro.
Project administration: Marı́a Luisa Soto-Montenegro.
Resources: Manuel Desco, Marı́a Luisa Soto-Montenegro.
Software: David Garcı́a-Garcı́a.
Supervision: Manuel Desco, Marı́a Luisa Soto-Montenegro.
Validation: Marta Casquero-Veiga, Marı́a Luisa Soto-Montenegro.
Writing – original draft: Marta Casquero-Veiga, Marı́a Luisa Soto-Montenegro.
Writing – review & editing: Marta Casquero-Veiga, Javier Pascau, Manuel Desco, Marı́a
Luisa Soto-Montenegro.
References
1. W.H.O. Obesity and Overweight [Internet]. 2018 [cited 9 Mar 2018]. Available: http://www.who.int/
mediacentre/factsheets/fs311/en/
2. Bastien M, Poirier P, Lemieux I, Després J-P. Overview of epidemiology and contribution of obesity to
cardiovascular disease. Prog Cardiovasc Dis. Elsevier Inc.; 2014; 56: 369–81. https://doi.org/10.1016/j.
pcad.2013.10.016 PMID: 24438728
3. Jebb S. Obesity: causes and consequences. Women’s Heal Med. 2004; 1: 38–41. https://doi.org/10.
1383/wohm.1.1.38.55418
4. Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis. Elsevier Inc.; 2014;
56: 465–472. https://doi.org/10.1016/j.pcad.2013.09.005 PMID: 24438739
5. Taylor J, Dietrich E, Powell J. New and emerging pharmacologic therapies for type 2 diabetes, dyslipi-
demia, and obesity. Clin Ther. 2013; 35: A3–17. https://doi.org/10.1016/j.clinthera.2012.12.012 PMID:
23328274
6. Stefater M a, Kohli R, Inge TH. Advances in the surgical treatment of morbid obesity. Mol Aspects Med.
Elsevier Ltd; 2013; 34: 84–94. https://doi.org/10.1016/j.mam.2012.10.006 PMID: 23089054
7. Halpern CH, Wolf J a, Bale TL, Stunkard AJ, Danish SF, Grossman M, et al. Deep brain stimulation in
the treatment of obesity. J Neurosurg. 2008; 109: 625–34. https://doi.org/10.3171/JNS/2008/109/10/
0625 PMID: 18826348
8. Chiken S, Nambu A. Disrupting neuronal transmission: mechanism of DBS? Front Syst Neurosci. 2014;
8: 1–9. https://doi.org/10.3389/fnsys.2014.00001
9. McIntyre CC, Anderson RW. Deep Brain Stimulation Mechanisms: The Control of Network Activity via
Neurochemistry Modulation. J Neurochem. 2016; 139: 338–345. https://doi.org/10.1111/jnc.13649
PMID: 27273305
10. Chiken S, Nambu A. Mechanism of Deep Brain Stimulation: Inhibition, Excitation, or Disruption? Neuro-
scientist. 2015; 22: 313–322. https://doi.org/10.1177/1073858415581986 PMID: 25888630
11. Kuhn J, Gaebel W, Klosterkoetter J, Woopen C. Deep brain stimulation as a new therapeutic approach
in therapy-resistant mental disorders: ethical aspects of investigational treatment. Eur Arch Psychiatry
Clin Neurosci. 2009;259 Suppl: S135–41. https://doi.org/10.1007/s00406-009-0055-8 PMID: 19876671
12. Hamani C, McAndrews MP, Cohn M, Oh M, Zumsteg D, Shapiro CM, et al. Memory enhancement
induced by hypothalamic/fornix deep brain stimulation. Ann Neurol. 2008; 63: 119–23. https://doi.org/
10.1002/ana.21295 PMID: 18232017
13. Voges J, Waerzeggers Y, Maarouf M, Lehrke R, Koulousakis A, Lenartz D, et al. Deep-brain stimula-
tion: Long-term analysis of complications caused by hardware and surgery-experiences from a single
centre. J Neurol Neurosurg Psychiatry. 2006; 77: 868–872. https://doi.org/10.1136/jnnp.2005.081232
PMID: 16574733
14. McGovern RA, Sheehy JP, Zacharia BE, Chan AK, Ford B, McKhann GM. Unchanged safety outcomes
in deep brain stimulation surgery for Parkinson disease despite a decentralization of care. J Neurosurg.
2013; 119: 1546–1555. https://doi.org/10.3171/2013.8.JNS13475 PMID: 24074498
15. Zrinzo L, Foltynie T, Limousin P, Hariz MI. Reducing hemorrhagic complications in functional neurosur-
gery: a large case series and systematic literature review. J Neurosurg. 2012; 116: 84–94. https://doi.
org/10.3171/2011.8.JNS101407 PMID: 21905798
Deep brain stimulation in obesity: A preclinical PET study
PLOS ONE | https://doi.org/10.1371/journal.pone.0204740 September 27, 2018 11 / 14
16. Shah RS, Chang S-Y, Min H-K, Cho Z-H, Blaha CD, Lee KH. Deep Brain Stimulation: Technology at the
Cutting Edge. J Clin Neurol. Korean Neurological Association; 2010; 6: 167–182. https://doi.org/10.
3988/jcn.2010.6.4.167 PMID: 21264197
17. Dougherty DD. Deep Brain Stimulation: Clinical Applications. Psychiatr Clin North Am. Elsevier Inc;
2018; https://doi.org/10.1016/j.psc.2018.04.004 PMID: 30098652
18. Sankar T, Tierney TS, Hamani C. Novel applications of deep brain stimulation. Surg Neurol Int. 2012; 3:
S26–33. https://doi.org/10.4103/2152-7806.91607 PMID: 22826807
19. Bétry C, Thobois S, Laville M, Disse E. Deep brain stimulation as a therapeutic option for obesity: A criti-
cal review. Obes Res Clin Pract. Asia Oceania Assoc. for the Study of Obesity; 2018; 2–11. https://doi.
org/10.1016/j.orcp.2018.02.004 PMID: 29475604
20. Taghva A, Corrigan JD, Rezai AR. Obesity and brain addiction circuitry: Implications for deep brain
stimulation. Neurosurgery. 2012; 71: 224–238. https://doi.org/10.1227/NEU.0b013e31825972ab
PMID: 22513843
21. Dupre D a, Tomycz N, Oh MY, Whiting D. Deep brain stimulation for obesity: past, present, and future
targets. Neurosurg Focus. 2015; 38: 1–9. https://doi.org/10.3171/2015.3.FOCUS1542.Disclosure
22. Halpern CH, Tekriwal A, Santollo J, Keating JG, Wolf JA, Daniels D, et al. Amelioration of binge eating
by nucleus accumbens shell deep brain stimulation in mice involves D2 receptor modulation. 2013; 33:
7122–7129. https://doi.org/10.1523/JNEUROSCI.3237-12.2013.Amelioration
23. Mantione M, van de Brink W, Schuurman PR, Denys D. Smoking cessation and weight loss after
chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case
report. Neurosurgery. 2010; 66: E218; discussion E218. https://doi.org/10.1227/01.NEU.0000360570.
40339.64 PMID: 20023526
24. Harat M, RudaśM, Zieliński P, Birska J, Sokal P. Nucleus accumbens stimulation in pathological obe-
sity. Neurol Neurochir Pol. 2016; 50: 207–210. https://doi.org/10.1016/j.pjnns.2016.01.014 PMID:
27154450
25. Klein J, Soto-Montenegro ML, Pascau J, Günther L, Kupsch A, Desco M, et al. A novel approach to
investigate neuronal network activity patterns affected by deep brain stimulation in rats. J Psychiatr
Res. Elsevier Ltd; 2011; 45: 927–30. https://doi.org/10.1016/j.jpsychires.2010.12.008 PMID: 21227451
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